Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 223-095-2 | CAS number: 3734-33-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with generally accepted scientific standards and described in sufficient detail
- Justification for type of information:
- data is from experimental reports following standard procedures
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 995
- Report date:
- 1995
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- other: OECD environment monograph no. 45 (OCDE/ GD (92)32
- Principles of method if other than guideline:
- Acute oral toxicity study of denatonium benzoate was performed in rats.
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- other: No data available
- Limit test:
- no
Test material
- Reference substance name:
- Denatonium benzoate
- EC Number:
- 223-095-2
- EC Name:
- Denatonium benzoate
- Cas Number:
- 3734-33-6
- Molecular formula:
- C21H29N2O.C7H5O2
- IUPAC Name:
- N-benzyl-2-[(2,6-dimethylphenyl)amino]-N,N-diethyl-2-oxoethanaminium benzoate hydrate
- Test material form:
- solid: granular
- Details on test material:
- - Name of test material: Denatonium benzoate
- Molecular formula: C21H29N2O.C7H5O2
- Molecular weight : 446.58 g/mol
- Substance type: organic
- Physical state: Solid
- SMILES: CCN{+}(CC)(Cc1ccccc1)(CC(=O)Nc1c(C)cccc1C).O{-}C(=O)c1ccccc1
Constituent 1
- Specific details on test material used for the study:
- - Name of test material (as cited in study report): N-benzyl-2-[(2,6-dimethylphenyl)amino]-N,N-diethyl-2-oxoethanaminium benzoate hydrate
-Common name: Denatonium benzoate
- Molecular formula: C21H29N2O.C7H5O2
- Molecular weight: 446.58 g/mol
- Substance type: organic
- Physical state: Solid
- Form: white granules
- purity:99.5%
- Storage conditions: room temperature, room temperature in the dark from 22 February, 1995
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Details on test animal
TEST ANIMALS
- Source: Charles river (UK) Ltd, Margate Kent.
- Age at study initiation:8-12 weeks old
- Weight at study initiation: male : 200-247g and female 200-250g
- Fasting period before study: An overnight fast immediately before dosing and for approximately two hours after dosing
- Housing: The animals were housed in group of up to five by sex in solid floor polypropylene cages furnished with wood flakes.
- Diet (e.g. ad libitum): food (Rat and mouse expanded diet no. 1,Special diets services limited , witham , Essex, uk)
- Water (e.g. ad libitum): Drinking water ad libitum
- Acclimation period:5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C):19 - 22°C
- Humidity (%):46-56%
- Air changes (per hr):15 changes
- Photoperiod (hrs dark / hrs light):12 hours continuous light and 12 hours darkness
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- Details on exposure
VEHICLE
- Concentration in vehicle:50.0,70.7,100.0 mg/kg
- Amount of vehicle (if gavage): 10mg/ml
- Justification for choice of vehicle: Test material dissolved in water
- Lot/batch no. (if required):No data available
- Purity: No data available
MAXIMUM DOSE VOLUME APPLIED: No data available
DOSAGE PREPARATION (if unusual):
The test material was freshly prepared, as required, as a solution at the appropriate concentration in distilled water.
CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: Range finding study was performed - Doses:
- 500,707, 1000mg/kg
- No. of animals per sex per dose:
- Total :30
500mg/kg : 5male and 5 female
707mg/kg : 5male and 5 female
1000mg/kg : 5male and 5 female - Control animals:
- not specified
- Details on study design:
- Details on study design
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing:1/2, 1,2 and 4 hour after dosing and subsequently once daily for 14 days animals were observed for death or overt signs of toxicity.
Individual body weights were recorded prior to dosing on day 0 and on days 7 and 14 or at death.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, gross pathological examination were performed and the appearance of any macroscopic abnormalities was recorded - Statistics:
- LD50 and 95% confidence limits were calculated using Thompson W.R ,
Results and discussion
- Preliminary study:
- Range finding study was performed
Effect levelsopen allclose all
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 749 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 664 - 845
- Remarks on result:
- other: 50% mortality was observed
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 841 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 707 - 1 000
- Remarks on result:
- other: 50% mortality was observed
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 648 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 506 - 832
- Remarks on result:
- other: 50% mortality was observed
- Mortality:
- Death were noted within 30 min of dosing or 2 to 4 hr after dosing
- Clinical signs:
- other: Hunched posture, lethargy and decreased respiratory rate were commonly noted on the day of dosing with additional signs of ataxia, labored respiration and noisy respiration. Clonic convulsions were noted in six animals prior to death. Incidents of hunched
- Gross pathology:
- Hemorrhagic lungs, dark liver, dark kidneys, pale gastric mucosa and haemorrhage or slight haemorrhage of the gastric mucosa were noted at necropsy of the animals that died during the study. No abnormalities were noted at necropsy of animals killed at the end of the study.
- Other findings:
- No data available
Applicant's summary and conclusion
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- LD50 values and 95% confidence limits of the test material denatonium benzoate(3734-33-6) in the Sprague –Dawley strain were calculated by the method of Thompson W.R to be for all animals: 749 (664-845) mg/kg bw, Males: 841(707-1000) mg/kg bw and Females: 648 (506-832) mg/kg bw.
- Executive summary:
In acute oral toxicity study male and female Sprague –Dawley rats were treated withdenatonium benzoate(3734-33-6).The animals were housed in group of up to five by sex in solid floor polypropylene cages furnished with wood flakes provided with food (Rat and mouse expanded diet no. 1, Special diets services limited, witham , Essex, uk) and drinking water ad libitum. An overnight fast immediately before dosing and for approximately two hours after dosing were done. The test material was freshly prepared, as required, as a solution at the appropriate concentration in distilled water. The dose concentration 500,707, 1000mg/kg were administered to 5 male and 5 female per dose group by oral gavage route in 10mg/ml volume. The Range finding study was performed for selection of dose concentration. All the animals were observed for 1/2, 1,2 and 4 hour after dosing and subsequently once daily for 14 days animals were observed for death or overt signs of toxicity. Individual body weights were recorded prior to dosing on day 0 and on days 7 and 14 or at death. Gross pathological examination was performed and the appearance of any macroscopic abnormalities was recorded. Deaths were noted within 30 min of dosing 1 female in 500mg/kg dose group while 2 females in 707 mg/kg dose group and 5 females and 4 males in 1000mg/kg dose group in which 2 animals were found dead within 1 or2 minutes of dosing. All the animals were died in 1000mg/kg dose group at the end of 4hr. Clinical signs like Hunched posture, lethargy and decreased respiratory rate were commonly noted on the day of dosing with additional signs of ataxia, labored respiration and noisy respiration. Clonic convulsions were noted in six animals prior to death. Incidents of hunched posture, lethargy, decreased respiratory rate, noisy respiration or labored respiration persisted up to 2 days after dosing. Surviving animals appeared normal 1 to 3 days after dosing or throughout the study. Surviving animals showed an acceptable increase in bodyweight during the study. Hemorrhagic lungs, dark liver, dark kidneys, pale gastric mucosa and haemorrhage or slight haemorrhage of the gastric mucosa were noted at necropsy of the animals that died during the study. No abnormalities were noted at necropsy of animals killed at the end of the study. Hence LD50 values and 95% confidence limits of the test material denatonium benzoate(3734-33-6) in the Sprague –Dawley strain were calculated by the method of Thompson W.R to be forall animals: 749 (664-845) mg/kg bw, Males: 841(707-1000) mg/kg bw and Females: 648 (506-832) mg/kg bw.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.